Anticoagulation Therapy Considerations in Factor VII Deficiency

Factor VII (FVII) deficiency is the most prevalent rare bleeding disorder in the USA and affects approximately 1 out of every 500,000 people. Warfarin inhibits the synthesis of FVII, in addition to other clotting factors. Warfarin is contraindicated in patients with bleeding tendencies or blood dysc...

Descripción completa

Detalles Bibliográficos
Autores principales: Paulus, Eric, Komperda, Kathy, Park, Gabriel, Fusco, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005634/
https://www.ncbi.nlm.nih.gov/pubmed/27747688
http://dx.doi.org/10.1007/s40800-016-0031-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005634/
https://www.ncbi.nlm.nih.gov/pubmed/27747688
http://dx.doi.org/10.1007/s40800-016-0031-y

Ejemplares similares